These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 24015508

  • 1. Protein-bearing cubosomes prepared by liquid precursor dilution: inner ear delivery and pharmacokinetic study following intratympanic administration.
    Liu H, Wang Y, Wang Q, Li Z, Zhou Y, Zhang Y, Li S.
    J Biomed Nanotechnol; 2013 Oct; 9(10):1784-93. PubMed ID: 24015508
    [Abstract] [Full Text] [Related]

  • 2. Self-assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: Improving preocular retention and ocular bioavailability.
    Gan L, Han S, Shen J, Zhu J, Zhu C, Zhang X, Gan Y.
    Int J Pharm; 2010 Aug 30; 396(1-2):179-87. PubMed ID: 20558263
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Revisiting β-casein as a stabilizer for lipid liquid crystalline nanostructured particles.
    Zhai J, Waddington L, Wooster TJ, Aguilar MI, Boyd BJ.
    Langmuir; 2011 Dec 20; 27(24):14757-66. PubMed ID: 22026367
    [Abstract] [Full Text] [Related]

  • 8. Formulation and development of bicontinuous nanostructured liquid crystalline particles of efavirenz.
    Avachat AM, Parpani SS.
    Colloids Surf B Biointerfaces; 2015 Feb 01; 126():87-97. PubMed ID: 25543986
    [Abstract] [Full Text] [Related]

  • 9. Cubosomes for topical delivery of the antimicrobial peptide LL-37.
    Boge L, Hallstensson K, Ringstad L, Johansson J, Andersson T, Davoudi M, Larsson PT, Mahlapuu M, Håkansson J, Andersson M.
    Eur J Pharm Biopharm; 2019 Jan 01; 134():60-67. PubMed ID: 30445164
    [Abstract] [Full Text] [Related]

  • 10. Size and phase control of cubic lyotropic liquid crystal nanoparticles.
    Hartnett TE, Ladewig K, O'Connor AJ, Hartley PG, McLean KM.
    J Phys Chem B; 2014 Jul 03; 118(26):7430-9. PubMed ID: 24915497
    [Abstract] [Full Text] [Related]

  • 11. Impact of preparation method and variables on the internal structure, morphology, and presence of liposomes in phytantriol-Pluronic(®) F127 cubosomes.
    Akhlaghi SP, Ribeiro IR, Boyd BJ, Loh W.
    Colloids Surf B Biointerfaces; 2016 Sep 01; 145():845-853. PubMed ID: 27315333
    [Abstract] [Full Text] [Related]

  • 12. Silica nanoparticle stabilization of liquid crystalline lipid dispersions: impact on enzymatic digestion and drug solubilization.
    Bhatt AB, Barnes TJ, Prestidge CA.
    Curr Drug Deliv; 2015 Sep 01; 12(1):47-55. PubMed ID: 25176029
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Microcontainers as an oral delivery system for spray dried cubosomes containing ovalbumin.
    Nielsen LH, Rades T, Boyd B, Boisen A.
    Eur J Pharm Biopharm; 2017 Sep 01; 118():13-20. PubMed ID: 27993733
    [Abstract] [Full Text] [Related]

  • 15. Nanostructured liquid crystalline particles provide long duration sustained-release effect for a poorly water soluble drug after oral administration.
    Nguyen TH, Hanley T, Porter CJ, Boyd BJ.
    J Control Release; 2011 Jul 30; 153(2):180-6. PubMed ID: 21497623
    [Abstract] [Full Text] [Related]

  • 16. Freeze-dried and re-hydrated liquid crystalline nanoparticles stabilized with disaccharides for drug-delivery of the plectasin derivative AP114 antimicrobial peptide.
    Boge L, Västberg A, Umerska A, Bysell H, Eriksson J, Edwards K, Millqvist-Fureby A, Andersson M.
    J Colloid Interface Sci; 2018 Jul 15; 522():126-135. PubMed ID: 29587194
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparative studies on glycerol monooleate- and phytantriol-based cubosomes containing oridonin in vitro and in vivo.
    Shi X, Peng T, Huang Y, Mei L, Gu Y, Huang J, Han K, Li G, Hu C, Pan X, Wu C.
    Pharm Dev Technol; 2017 May 15; 22(3):322-329. PubMed ID: 26670780
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.